Teratogenic Effects of Intravitreal Injection of Bevacizumab in a Pregnant Rat Model

Authors

  • Behzad Khademi Residence of Ophthalmology, Department of ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mahsa Khanlari Pathologist, Department of Pathology, Dr Daneshbod Laboratory, Shiraz, Iran
  • Mina Bamdad Master of Science in developmental Biology, Department of Developmental Biology, Islamic Azad University, Fars, Iran
  • Shahram Bamdad Assistand Professor of ophthalmology, Department of ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Yahya Daneshbod Pathologist, Department of Pathology, Dr Daneshbod Laboratory, Shiraz, Iran
Abstract:

Abstract: Title: Teratogenic Effects of Intravitreal Injection of Bevacizumab in Pregnant Rat Models Aim: To investigate teratogenic effect of intravitreal injection of bevacizumab in pregnant rat model Methods: Twenty seven female Wistar rat were inseminated. Pregnant rats were divided into 6 groups (three groups as case and three as control groups). Each case and control groups divided according to the day of intravitreal injections (day 2, 10 and 18). Rats in the case groups received 4 µl intravitreal injection of bevacizumab and the control groups received same volume of distilled water. Results: The tail and umbilical cord length in case groups 1, 2 and 3 did not display any significant differences compared with their control groups. The fetal weight was significantly lower in the case groups 1 (p

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Intravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization

We report a 64-year-old diabetic woman who developed neovascularization of the posterior capsule 2 years after cataract surgery and intraocular lens implantation. The patient was treated with single injection of 1.25 mg of intravitreal bevacizumab (Avastin) via pars plana. After one week, complete regression of the posterior capsule neovascularization was achieved allowing us to perform Nd: YAG...

full text

Comparison of Intravitreal Injection of Bevacizumab and Triamcinolone Acetonide in the Treatment of Uveitic Macular Edema

Background: Cystoid Macular Edema (CME) is one of the most common and sight threatening complications of uveitis. Intravitreal injection of corticosteroids and anti-VEGF antibody are two routine options for treatment. Objective: To compare the effects of intravitreal injections of Bevacizumab and Triamcinolone Acetonide for the treatment of persistent macular edema in non-infectious uveitis. Me...

full text

Improvement of Diabetic Macular Edema in the Fellow Eye After Monocular Intravitreal Bevacizumab Injection

Introduction: Because of bilateral involvement in many cases with diabetic macular edema, Intravitreal bevacizumab injection perform in both eyes. There are some reports of therapeutic effects in the fellow eye after monocular injection of anti-vascular endothelial growth factors. In this study we describe a case of bilateral improvement of diabetic macular edema following unil...

full text

Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.

Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 16  issue 2

pages  670- 676

publication date 2017-06-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023